Drug cost avoidance analysis of cancer clinical trials in Spain: a study on cost contributors and their impact

• Päätekijät: Domingo Antonio Sánchez Martínez (Tekijä), Federico Salas-Lucia (Tekijä), Hanzi Jiang (Tekijä), Paula Ruiz-Carreño (Tekijä), José Luis Alonso Romero (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: BMC, 2022-07-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Objective Analyze the cost contributors and their impact on the drug cost avoidance (DCA) resulting from cancer clinical trials over the period of 2015-2020 in a tertiary-level hospital in Spain (HCUVA). Methods We performed a cross-sectional, observational, retrospective study of a total o...